Actavis Group PTC ehf., Merckle GmbH, PLIVA Croatia Ltd., Teva Operations Poland Sp. z o.o., Teva Pharma B.V.

The medicine is used to treat liver cancer, advanced kidney cancer (when standard therapy is ineffective or not indicated), and differentiated thyroid cancer.

Dosage form: tablets, film-coated

ATC: L01EX02